The field of mesenchymal stem cell (MSC) research continues to gain momentum as scientists and innovators push the boundaries of regenerative medicine, tissue engineering, and biotechnology. From developing engineered tissues to advancing cell-based therapies, MSCs are at the heart of these groundbreaking efforts. As a result, the demand for high-quality MSC research products has grown rapidly. Whether you’re involved with research, clinical applications, or biomanufacturing, knowing where to find reliable MSC tools is essential for success. [Read more…]
What is Cell Reprogramming and What Does It Mean?
Can you imagine a world where doctors have the power to replace dead, disease-causing cells with healthy ones produced in a laboratory? With continued research into cell reprogramming that future isn’t far off. There have already been several successful trials with this technology. Despite its immense potential and expanding use, many individuals still remain unfamiliar with the concept of cell reprogramming.
So, what is cell reprogramming? And what are some of the obstacles that the field faces today? In this quick summary of cell reprogramming, we’ll answer these questions and more. [Read more…]
SB431542 Unlocking the Potential of Mouse Embryonic Stem Cells
Mouse embryonic stem cells (mESCs) have long stood as a cornerstone of regenerative medicine and developmental biology research. Derived from the inner cell mass of blastocyst-stage mouse embryos, these cells possess two defining characteristics: pluripotency, the ability to differentiate into any cell type in the adult body, and self-renewal, the capacity to divide indefinitely while maintaining that pluripotent state. Harnessing these properties, however, requires precise control over the cellular signaling pathways that govern mESC fate. This is where SB431542, a small molecule inhibitor, emerges as a powerful tool—one that has revolutionized how researchers manipulate mESCs in the lab. [Read more…]
Cord Blood Industry Trends – Clinical Trials, Publications, Patents, Grants, & More
With the global cord blood banking industry maturing and consolidating over the past five years, it is more important than ever to be well-educated about cord blood industry trends. There are now fewer market players, because numerous small cord blood banks have either been acquired or gone out of business.
However, this era of maturation and consolidation has had as many benefits to surviving cord blood banks as drawbacks. On average, the remaining market participants are now larger, stronger, better capitalized, and storing larger quantities of cord blood and tissue units than when the market was more fragmented.
List of U.S. Cord Blood Banks – Public, Private, and Hybrid
A cord blood and tissue bank is a facility that collects, processes, and stores stem cells from a newborn’s umbilical cord blood and tissue for potential future use in medical treatments. These banks preserve the stem cells for therapies such as transplants for blood cancers or genetic disorders and may also store tissue for regenerative medicine applications​
This sortable list below includes all known Public, Private, and Hybrid Cord Blood Banks in the United States, including:
- Private cord blood banks store cord blood units for private use by individual families (for a fee)
- Public cord blood banks store cord blood donations for public use (free of cost)
- Hybrid cord blood banks offer both public and private cord blood banking services
Currently, Cord Blood Registry (CBR) is the largest U.S. cord blood bank with over one million cord blood and tissue units in storage. The next largest cord blood banks in the U.S. are Viacord and Cryo-Cell.
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 334
- Next Page »